See more : Pacific Textiles Holdings Limited (1382.HK) Income Statement Analysis – Financial Results
Complete financial analysis of SpectraCure AB (publ) (SPEC.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SpectraCure AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- Chang Chun Eurasia Group Co., Ltd. (600697.SS) Income Statement Analysis – Financial Results
- IG Design Group plc (IGDFF) Income Statement Analysis – Financial Results
- Al Gassim Investment Holding Company (6020.SR) Income Statement Analysis – Financial Results
- Playa Hotels & Resorts N.V. (PLYA) Income Statement Analysis – Financial Results
- Canoe Mining Ventures Corp. (CNMVF) Income Statement Analysis – Financial Results
SpectraCure AB (publ) (SPEC.ST)
About SpectraCure AB (publ)
SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 318.00K | 539.00K | 0.00 | 1.21K | 763.00 | 596.00K | 258.95K | 172.91K | 778.50K | 476.20K | 1.49M |
| Cost of Revenue | 9.54M | -3.05M | -1.39M | -2.35M | -2.62M | -2.13M | -1.55M | -1.14M | -249.43K | -641.87K | 67.73K |
| Gross Profit | -9.22M | 3.59M | 1.39M | 2.35M | 2.62M | 2.72M | 1.81M | 1.31M | 1.03M | 1.12M | 1.42M |
| Gross Profit Ratio | -2,900.31% | 665.12% | 0.00% | 194,154.50% | 343,088.20% | 456.54% | 699.85% | 758.00% | 132.04% | 234.79% | 95.45% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 11.62M | 10.69M | 8.32M | 7.82M | 6.55M | 5.93M | 5.21M | 5.07M | 3.68M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 30.91M | 11.62M | 10.69M | 8.32M | 7.82M | 6.55M | 5.93M | 5.21M | 5.07M | 3.68M | 4.75M |
| Other Expenses | -18.78M | 18.40M | 15.11M | 10.49M | 9.08M | 134.00K | 4.58M | 2.92M | 1.71M | 1.49M | 0.00 |
| Operating Expenses | 12.13M | 30.02M | 25.80M | 18.82M | 16.91M | 11.90M | 10.51M | 8.13M | 6.78M | 5.17M | 7.02M |
| Cost & Expenses | 21.67M | 26.98M | 24.42M | 16.47M | 14.29M | 9.78M | 8.96M | 6.99M | 6.53M | 4.53M | 7.09M |
| Interest Income | 1.95M | 537.00K | 216.00K | 158.00K | 97.00K | 7.00K | 51.00 | 550.00 | 510.00 | 1.65K | 132.26K |
| Interest Expense | 522.00K | 182.00K | 245.00K | 276.00K | 224.00K | 0.00 | 64.00 | 43.51K | 134.09K | 291.41K | 0.00 |
| Depreciation & Amortization | 505.00K | 2.93M | 2.67M | 2.28M | 2.12M | 150.00K | 1.17M | 136.83K | 53.85K | 1.19M | 2.51M |
| EBITDA | -20.97M | -22.27M | -20.43M | -12.88M | -11.35M | -9.46M | -7.53M | -6.24M | -5.69M | -2.87M | -3.09M |
| EBITDA Ratio | -6,594.03% | -4,140.63% | 0.00% | -1,063,748.97% | -1,487,942.33% | -1,615.27% | -2,907.20% | -3,862.54% | -731.75% | -602.44% | -207.69% |
| Operating Income | -21.35M | -26.98M | -24.42M | -16.47M | -14.29M | -9.62M | -8.70M | -6.82M | -5.75M | -4.06M | -5.60M |
| Operating Income Ratio | -6,714.15% | -5,005.19% | 0.00% | -1,359,620.15% | -1,872,608.13% | -1,613.59% | -3,358.37% | -3,941.99% | -738.73% | -851.79% | -375.80% |
| Total Other Income/Expenses | 889.00K | 355.00K | -29.00K | -118.00K | -127.00K | 826.00K | -13.00 | 444.02K | -133.58K | -289.77K | -132.26K |
| Income Before Tax | -20.46M | -25.38M | -23.35M | -15.44M | -13.69M | -9.61M | -8.70M | -6.37M | -5.88M | -4.35M | -5.73M |
| Income Before Tax Ratio | -6,434.59% | -4,708.53% | 0.00% | -1,274,731.63% | -1,794,495.41% | -1,612.42% | -3,358.38% | -3,685.20% | -755.89% | -912.64% | -384.67% |
| Income Tax Expense | -21.00K | -53.00K | -5.00K | -30.00K | -7.00K | 167.00K | 51.00 | 550.00 | 510.00 | 1.65K | 0.00 |
| Net Income | -20.44M | -25.33M | -23.34M | -15.41M | -13.69M | -9.61M | -8.70M | -6.37M | -5.88M | -4.35M | -5.73M |
| Net Income Ratio | -6,427.99% | -4,698.70% | 0.00% | -1,272,254.34% | -1,793,577.98% | -1,612.42% | -3,358.38% | -3,685.20% | -755.89% | -912.64% | -384.67% |
| EPS | -0.21 | -0.26 | -0.24 | -0.17 | -0.16 | -0.12 | -0.15 | -0.21 | -0.16 | -0.12 | -0.37 |
| EPS Diluted | -0.21 | -0.26 | -0.24 | -0.17 | -0.16 | -0.12 | -0.15 | -0.21 | -0.16 | -0.12 | -0.35 |
| Weighted Avg Shares Out | 97.13M | 97.13M | 97.13M | 92.41M | 83.10M | 78.40M | 57.10M | 30.25M | 36.30M | 36.30M | 15.33M |
| Weighted Avg Shares Out (Dil) | 97.13M | 97.13M | 97.13M | 92.41M | 83.10M | 78.40M | 57.10M | 30.25M | 36.30M | 36.30M | 16.42M |
Source: https://incomestatements.info
Category: Stock Reports